Purification, biochemical characterization and self-assembled structure of a fengycin-like antifungal peptide from bacillus thuringiensis strain SM

Frontiers in Microbiology

Volumn 4, Issue NOV, 2013, Pages

  Roy, Anupam ^a   Mahata, Denial ^a   Paul, Debarati ^b   Korpole, Suresh ^c   Franco, Octavio L ^d   Mandal, Santi M ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b AMITY UNIVERSITY   (India)

^c INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

^d Centro de Analises Proteomicas e Bioquimicas   (Brazil)

Author keywords

Antimicrobial activity; Bacillus thuringiensis; Fengycin; Self assembled structure

Indexed keywords

ANTIFUNGAL AGENT; CATALASE; FENGYCIN; LIPOPEPTIDE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS THURINGIENSIS; BACTERIAL STRAIN; CANDIDA ALBICANS; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG PURIFICATION; DRUG STRUCTURE; FATTY ACID ANALYSIS; FLOW RATE; INFRARED SPECTROSCOPY; MASS FRAGMENTOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCANNING ELECTRON MICROSCOPY; SELF ASSEMBLED STRUCTURE;

EID: 84890307990     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00332     Document Type: Article

References (27)

1. Anantharaman, A., Rizvi, M. S., and Sahal, D. (2010). Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectively of de novo-designed antimicrobial peptides. Antimicrob. Agents Chemother. 54, 1693e1699. doi: 10.1128/AAC.01231-09.
2. Baindara, P., Mandal, S. M., Chawla, N., Singh, P. K., Pinnaka, A. K., and Korpole, S. (2013). Characterization of two antimicrobial peptides produced by a halotolerant Bacillus subtilis strain SK.DU.4 isolated from a rhizosphere soil sample. AMB Express 5, 32. doi: 10.1186/2191-0855-3-2.
3. Deleu, M., Paquot, M., and Nylander, T. (2005). Fengycin interaction with lipid monolayers at the air-aqueous interface-implications for the effect of fengycin on biological membranes. J. Colloid Interface Sci. 283, 358-365. doi: 10.1016/j.jcis.2004.09.036.
4. Deleu, M., Paquot, M., and Nylander, T. (2008). Effect of fengycin, a lipopeptide produced by Bacillus subtilis, on model biomembranes. Biophys. J. 94, 2667-2679. doi: 10.1529/biophysj.107.114090.
5. Fernandez-Lopez, S., Kim, H. S., Choi, E. C., Delgado, M., Granja, J. R., Khasanov, A., et al. (2001). Antibacterial agents based on the cyclic D,L-α-peptide architecture. Nature 412, 452-455. doi: 10.1038/35086601.
6. Gilsdorf, J. R., and Zilinskas, R. A. (2005). New considerations in infectious disease outbreaks: The threat of genetically modified microbes. Clin. Infect. Dis. 40, 1160-1165. doi: 10.1086/428843.
7. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41, 95-98.
8. Hathout, Y., Ho, Y. P., Ryzhov, V., Demirev, P., and Fenselau, C. (2000). Kurstakins: a new class of lipopeptides isolated from Bacillus thuringiensis. J. Nat. Prod. 63, 1492-1496. doi: 10.1021/np000169q.
9. Hbid, C. (1996). Contribution à l'étude de la Relation Entre la Structure des Lipopeptides de B. subtilis et leurs Activités Hémolytique et Antifongique. Ph.D. thesis, Université de Liège, Belgium.
10. Hüttl, C., Hettrich, C., Miller, R., Paulke, B. R., Henklein, P., Rawel, H., et al. (2013). Self-assembled peptide amphiphiles function as multivalent binder with increased hemagglutinin affinity BMC Biotechnol. 13:51. doi: 10.1186/1472-6750-13-51.
11. Jones, K. E., Patel, N. J., Levy, M. A., Storeygard, A., Balk, D., Gittleman, J. L., et al. (2008). Global trends in emerging infectious diseases. Nature 451, 990-993. doi: 10.1038/nature06536.
12. Kimura, M. (1980). A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16, 111-120. doi: 10.1007/BF01731581.
13. Korpole, S., Mayilraj, S., and Chakrabarti, T. (2006). Effluviibacter roseus gen. nov. sp. nov., isolated from muddy water, belonging to the family "Flexibacteraceae". Int. J. Syst. Evol. Microbiol. 56, 1703-1707. doi: 10.1099/ijs.0.64144-0.
14. Loeffler, W., Tschen, J. S. M., Vanittanakom, N., Kugler, M., Knorpp, E., Hsieh, T. F., et al. (1986). Antifungal effects of bacilysin and fengymycin from Bacillus subtilis F-29-3 a comparsion with activities of other Bacillus antibiotics. J. Phytopathol. 115, 204-213. doi: 10.1111/j.1439-0434.1986.tb00878.x.
15. Mandal, S. M., Sharma, S., Pinnaka, A. K., Kumari, A., and Suresh, K. (2013). Isolation and characterization of diverse antimicrobial lipopeptides produced by citrobacter and enterobacter. BMC Microbiol. 13:152. doi: 10.1186/1471-2180-13-152.
16. Pathak, K. V., Keharia, H., Gupta, K., Thakur, S. S., and Balaram, P. (2012). Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins. J. Am. Soc. Mass. Spectrom. 1716-1728. doi: 10.1007/s13361-012-0437-4.
17. Roy, A., Franco, O. L., and Mandal, S. M. (2013). Biomedical exploitation of self assembled peptide based nanostructures. Curr. Protein Pept. Sci. 14, 07.
18. Samanta, T., Roymahapatra, G., Porto, W. F., Seth, S., Ghorai, S., Saha, S., et al. (2013). N, N'-olefin functionalized bis-imidazolium gold(I) salt is an efficient candidate to control keratitis-associated eye infection. PLoS ONE 8:e58346. doi: 10.1371/journal.pone.0058346.
19. Schneider, J., Taraz, K., Budzikiewicz, H., Deleu, M., Thonart, P., and Jacques, P. Z. (1999). The structure of two fengycins from Bacillus subtilis S499. Z. Naturforsch. C 54, 859-865.
20. Steller, S., and Vater, J. (2000). Purification of the fengycin synthetase multienzyme system from Bacillus subtilis b213. J. Chromatogr. B Biomed. Sci. Appl. 737, 267-275. doi: 10.1016/S0378-4347(99)00481-8.
21. Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., and Kumar, S. (2011). MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance and maximum parsimony methods. Mol. Biol. Evol. 28, 2731-2739. doi: 10.1093/molbev/msr121.
22. Vanittanakom, N., Loeffler, W., Koch, U., and Jung, G. (1986). Fengycin-a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J. Antibiot. (Tokyo) 39, 888-901 doi: 10.7164/antibiotics.39.888.
23. Vass, E., Besson, F., Majer, Z., Volpon, L., and Hollosi, M. (2001). Ca(2+)-induced changes of surfactin conformation: a FTIR and circular dichroism study. Biochem. Biophy. Res. Commun. 282, 361-367. doi: 10.1006/bbrc.2001.4469.
24. Vass, E., Hollosi, M., Besson, F., and Buchet, R. (2003). Vibrational spectroscopic detection of beta-and gamma-turns in synthetic and natural peptides and proteins. Chem. Rev. 103, 1917-1954. doi: 10.1021/cr000100n.
25. Vass, E., Kurz, M., Konat, R. K., and Hollosi, M. (1998). FTIR and CD spectroscopic studies on cyclic penta-and hexa-peptides. Detailed examination of hydrogen bonding in b-and c-turns determined by NMR. Spectrochim. Acta A 54, 773-786. doi: 10.1016/S1386-1425(98)00028-6.
26. Vass, E., Majer, Z., Kohalmy, K., and Hollosi, M. (2010). Vibrational and chiroptical spectroscopic characterization of gamma-turn model cyclic tetrapeptides containing two beta-Ala residues. Chirality 22, 762-771. doi: 10.1002/chir.20831.
27. Vater, J., Kablitz, B., Wilde, C., Franke, P., Mehta, N., and Cameotra, S. S. (2002). Matrix-assisted laser desorbtion ionization-time of flight mass spectrometry of lipopeptide biosurfactants in whole cells and culture filtrates of Bacillus subtilis C-1 isolated from petroleum sludge. Appl. Environ. Microbiol. 68, 6210-6219. doi: 10.1128/AEM.68.12.6210-6219.2002.